Germany · Delayed Price · Currency is EUR Utah Medical Products Statistics
Total Valuation
FRA:UTM has a market cap or net worth of EUR 163.75 million. The enterprise value is 91.76 million.
| Market Cap | 163.75M |
| Enterprise Value | 91.76M |
Important Dates
The last earnings date was Friday, January 30, 2026.
| Earnings Date | Jan 30, 2026 |
| Ex-Dividend Date | Dec 16, 2025 |
Share Statistics
| Current Share Class | 3.19M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -7.51% |
| Shares Change (QoQ) | -0.31% |
| Owned by Insiders (%) | 7.18% |
| Owned by Institutions (%) | 62.91% |
| Float | 2.77M |
Valuation Ratios
The trailing PE ratio is 17.04.
| PE Ratio | 17.04 |
| Forward PE | n/a |
| PS Ratio | 4.99 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.55 |
| EV / Sales | 2.83 |
| EV / EBITDA | 7.57 |
| EV / EBIT | 9.56 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 37.62, with a Debt / Equity ratio of 0.00.
| Current Ratio | 37.62 |
| Quick Ratio | 34.36 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.54% and return on invested capital (ROIC) is 26.84%.
| Return on Equity (ROE) | 9.54% |
| Return on Assets (ROA) | 5.82% |
| Return on Invested Capital (ROIC) | 26.84% |
| Return on Capital Employed (ROCE) | 9.51% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 203,773 |
| Profits Per Employee | 59,704 |
| Employee Count | 167 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.97 |
Taxes
In the past 12 months, FRA:UTM has paid 2.41 million in taxes.
| Income Tax | 2.41M |
| Effective Tax Rate | 20.01% |
Stock Price Statistics
The stock price has decreased by -11.97% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.97% |
| 50-Day Moving Average | 48.34 |
| 200-Day Moving Average | 48.51 |
| Relative Strength Index (RSI) | 49.35 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.88 |
Income Statement
In the last 12 months, FRA:UTM had revenue of EUR 32.81 million and earned 9.61 million in profits. Earnings per share was 2.97.
| Revenue | 32.81M |
| Gross Profit | 18.74M |
| Operating Income | 9.71M |
| Pretax Income | 12.02M |
| Net Income | 9.61M |
| EBITDA | 12.22M |
| EBIT | 9.71M |
| Earnings Per Share (EPS) | 2.97 |
Balance Sheet
The company has 73.04 million in cash and 191,633 in debt, with a net cash position of 72.85 million.
| Cash & Cash Equivalents | 73.04M |
| Total Debt | 191,633 |
| Net Cash | 72.85M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 101.58M |
| Book Value Per Share | 31.88 |
| Working Capital | 81.03M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 57.12%, with operating and profit margins of 29.60% and 29.30%.
| Gross Margin | 57.12% |
| Operating Margin | 29.60% |
| Pretax Margin | 36.63% |
| Profit Margin | 29.30% |
| EBITDA Margin | 37.24% |
| EBIT Margin | 29.60% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.07, which amounts to a dividend yield of 2.07%.
| Dividend Per Share | 1.07 |
| Dividend Yield | 2.07% |
| Dividend Growth (YoY) | -4.22% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.51% |
| Shareholder Yield | 9.58% |
| Earnings Yield | 5.87% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |